← All Oramed Pharmaceuticals INC filings

Oramed Pharmaceuticals INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
ORMP
Oramed Pharmaceuticals INC
DEF: Oramed Pharmaceuticals Schedules 2025 Annual Meeting, Seeks Shareholder Approval for Key Governance and Incentive Plan Updates
Oramed Pharmaceuticals Inc. announced its 2025 Annual Meeting of Stockholders to be held on August 19, 2025, seeking approval for director re-elections, auditor ratification, and an increase in its stock incentive plan shares.
NASDAQ
ORMP
Oramed Pharmaceuticals INC
DEF 14A: Oramed Pharmaceuticals Sets Date for Annual Stockholders Meeting, Director Re-Election and Executive Compensation on the Agenda
Oramed Pharmaceuticals will hold its annual meeting of stockholders on August 1, 2024, to vote on director re-elections, executive compensation, and auditor ratification.